FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden. Issue 8 (8th May 2021) - Yilmaz, Musa; Daver, Naval; Borthakur, Gautam; Kadia, Tapan; DiNardo, Courtney; Kanagal‐Shamanna, Rashmi; Loghavi, Sanam; Oran, Betul; Popat, Uday R.; Pierce, Sherry; Jabbour, Elias; Short, Nicholas J.; et al.